| P50 | author | Jenny L. Wiley | Q42407062 |
| P2093 | author name string | Aron H Lichtman | |
| | R Allen Owens | |
| P2860 | cites work | Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations | Q24309438 |
| | Brain monoglyceride lipase participating in endocannabinoid inactivation | Q24533828 |
| | Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. | Q45173372 |
| | Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors. | Q45937148 |
| | Abuse potential of dronabinol (Marinol). | Q46392742 |
| | Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats | Q46819535 |
| | Cannabidiol monotherapy for treatment-resistant schizophrenia | Q46886103 |
| | The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport | Q48315882 |
| | Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol | Q48665304 |
| | Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol | Q48729157 |
| | Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats: a systematic replication. | Q52168218 |
| | Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats. | Q52180495 |
| | Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats. | Q52202168 |
| | Generalization of the discriminative stimulus properties of delta 9-THC to delta 9(11)-THC in rats. | Q52270952 |
| | A repeated test procedure to assess onset and duration of the cue properties of (-) delta 9-THC, (-) delta 8-THC-DMH and (+) delta 8-THC. | Q52296052 |
| | ?9-THC as a discriminative stimulus in rats and pigeons: Generalization to THC metabolites and SP-111 | Q52300665 |
| | Δ9-tetrahydrocannabinol produced discrimination in pigeons | Q52311761 |
| | Δ9-Tetrahydrocannabinol and pentobarbital as discriminative cues in the Mongolian gerbil (Meriones unguiculatus) | Q52312961 |
| | 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? | Q55051416 |
| | Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish | Q55871276 |
| | Design, Synthesis and Pharmacology of Cannabimimetic Indoles | Q56552041 |
| | Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase | Q24555807 |
| | N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipase | Q24569817 |
| | Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects | Q24606148 |
| | Cannabinergic aminoalkylindoles, including AM678=JWH018 found in 'Spice', examined using drug (Δ(9)-tetrahydrocannabinol) discrimination for rats | Q24630223 |
| | The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin | Q24643876 |
| | Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain | Q27655121 |
| | Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 |
| | Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist | Q28262546 |
| | Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity | Q28265080 |
| | Identification and functional characterization of brainstem cannabinoid CB2 receptors | Q28276972 |
| | Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides | Q28295481 |
| | The pharmacology of cannabinoid receptors and their ligands: an overview | Q28304279 |
| | Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta9-tetrahydrocannabinol | Q28833498 |
| | Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 |
| | A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N–OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products | Q30052011 |
| | Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. | Q30492114 |
| | Synthetic cannabinoids as designer drugs: new representatives of indol-3-carboxylates series and indazole-3-carboxylates as novel group of cannabinoids. Identification and analytical data | Q30859184 |
| | Cannabis: discrimination of "internal bliss"? | Q33748898 |
| | Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism | Q33840797 |
| | Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents | Q33948790 |
| | Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs | Q34028114 |
| | "Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays | Q34055910 |
| | JWH-018 in rhesus monkeys: differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects. | Q34098379 |
| | Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats | Q34115633 |
| | Spice drugs as a new trend: mode of action, identification and legislation | Q34121927 |
| | Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice | Q34203193 |
| | 3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism | Q34232856 |
| | 1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice | Q34236794 |
| | Differential effects of delta9-tetrahydrocannabinol and methanandamide in CB1 knockout and wild-type mice | Q34289368 |
| | URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products | Q34305905 |
| | A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats | Q34339667 |
| | Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors | Q37186197 |
| | Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol | Q37266063 |
| | Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice | Q37339113 |
| | Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles | Q37397048 |
| | Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model | Q37594706 |
| | Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats | Q37625769 |
| | In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects. | Q37637750 |
| | Phytocannabinoids as novel therapeutic agents in CNS disorders. | Q37933589 |
| | Discriminative stimulus properties of tetrahydrocannabinols and related drugs in rats and pigeons | Q40286992 |
| | Just add water: cannabinoid discrimination in a water T-maze with FAAH(-/-) and FAAH(+/+) mice | Q41847079 |
| | O-hydroxyacetamide carbamates as a highly potent and selective class of endocannabinoid hydrolase inhibitors | Q41971391 |
| | Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system | Q42882543 |
| | In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: inhalation versus intraperitoneal injection | Q43162678 |
| | (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide | Q43703172 |
| | Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys | Q44492000 |
| | Discriminative stimulus effects of the cannabinoid antagonist, SR 141716A, in delta -sup-9-tetrahydrocannabinol-treated rhesus monkeys | Q44643235 |
| | Medicinal cannabis: is delta9-tetrahydrocannabinol necessary for all its effects? | Q44738502 |
| | Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia | Q44902561 |
| | Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB1 receptor antagonist | Q44914228 |
| | Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task | Q44924131 |
| | Pharmacological specificity of the phencyclidine discriminative stimulus in rats | Q44937164 |
| | Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats | Q45081448 |
| | Discriminative stimulus effects of anandamide in rats | Q45084272 |
| | Discriminative stimulus effects of delta 9-tetrahydrocannabinol and delta 9-11-tetrahydrocannabinol in rats and rhesus monkeys | Q45092872 |
| | Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys | Q45098382 |
| | Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys | Q45108581 |
| | Evaluation of cannabimimetic effects of structural analogs of anandamide in rats | Q45113957 |
| | Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids. | Q34373631 |
| | 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles | Q34432451 |
| | Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2/Spice | Q34437634 |
| | Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoids. | Q34452595 |
| | AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice | Q34482035 |
| | Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism | Q34714609 |
| | Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity | Q34756953 |
| | The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice | Q34766609 |
| | Indoles and related compounds as cannabinoid ligands | Q34778147 |
| | Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice | Q34846838 |
| | Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. | Q34978868 |
| | The enzymatic inactivation of the fatty acid amide class of signaling lipids | Q35035840 |
| | Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicle | Q35162907 |
| | Δ9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication | Q35226616 |
| | The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys | Q35287465 |
| | Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice | Q35287466 |
| | Simultaneous inhibition of fatty acid amide hydrolase and monoacylglycerol lipase shares discriminative stimulus effects with Δ9-tetrahydrocannabinol in mice | Q35531797 |
| | Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice | Q35531804 |
| | JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys | Q35650744 |
| | Task-specific enhancement of hippocampus-dependent learning in mice deficient in monoacylglycerol lipase, the major hydrolyzing enzyme of the endocannabinoid 2-arachidonoylglycerol | Q35672120 |
| | Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride | Q35685476 |
| | Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market | Q35836423 |
| | Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates | Q35992150 |
| | Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice | Q36020820 |
| | Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys | Q36174226 |
| | The unfolding cannabinoid story on energy homeostasis: central or peripheral site of action? | Q36434437 |
| | Recent clinical experience with dronabinol | Q36466260 |
| | Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol | Q36517347 |
| | Novel 3-substituted rimonabant analogues lack Δ(9) -tetrahydrocannabinol-like abuse-related behavioural effects in mice | Q36783972 |
| | Discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats | Q36919559 |
| | Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa. | Q36936213 |
| | FAAH deficiency promotes energy storage and enhances the motivation for food | Q37006692 |
| | Discriminative stimulus functions in rats of AM1346, a high-affinity CB1R selective anandamide analog | Q37055254 |
| | Discriminative stimulus functions of methanandamide and delta(9)-THC in rats: tests with aminoalkylindoles (WIN55,212-2 and AM678) and ethanol | Q37055277 |
| P921 | main subject | cannabinoids | Q422936 |
| | endocannabinoids | Q10483908 |
| P577 | publication date | 2016-06-09 | |
| P1433 | published in | Current topics in behavioral neurosciences | Q26842118 |
| P1476 | title | Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids | |